Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Palo Alto Networks

    Protecting Pharma from cyber attacks and systems misuse helping to ensure IP Protection and availability in manufacturing environments

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    Genetic Digital

    We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

    View Profile

    Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

    - PMLiVE

    Nmblr

    From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

    View Profile

    IT solutions

    Company Details

    Palo Alto Networks
    4401 Great America Parkway, Santa Clara, CA, 95054, USA
    Contact Palo Alto Networks
    Website

     Latest Content from PMHub 

    5 Ways to Communicate With Millennials About Healthcare

    White Papers and Resources | March 4, 2019 | Say Communications

    What does it mean to be a millennial? Opinions vary greatly and it is difficult to disagree on the exact definition. Metro explained the generation as babies born from the...

    Webcast: Poker face revealed: Using facial analysis to uncover deeper levels of emotional insight

    White Papers and Resources | March 1, 2019 | Inizio

    In the first part of our series covering market research innovations which have value in healthcare, we demonstrate how we've been using facial analysis to delve further into respondents' reactions...

    Report: Living with RA (EU, Japan and Canada) 2019 reports

    White Papers and Resources | March 1, 2019 | Inizio

    Research Partnership launches new patient Living with  Rheumatoid Arthritis (EU & Japan)  2019 report.r Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in...

    News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

    White Papers and Resources | March 1, 2019 | Inizio

    A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter. In addition from Q1...

    Emerging Markets: Your Essential Guide

    White Papers and Resources | March 1, 2019 | Inizio

    Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges...

    Live webinar: Navigating new frontiers: Ways to find space in the future RA market

    White Papers and Resources | March 1, 2019 | Inizio

    In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...

    Bluedog Launch Celebrations

    Videos and Podcasts | February 28, 2019 | Lucid Group Communications Limited

    Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary.  2019 is set to be a...

    Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis

    Press Releases | February 28, 2019 | Porterhouse Medical Group

    An interview with Debbie, office manager at Porterhouse Medical, on what it’s like to live with the rare disease, PSC. Read more ...

    Rare Disease Day 2019

    White Papers and Resources | February 28, 2019 | Cuttsy + Cuttsy

    Today is #RareDiseaseDay and is an opportunity to highlight some truly unbelievable/frightening statistics around rare diseases.

    Health Literacy in Practice: Doctor’s Letter

    White Papers and Resources | February 25, 2019 | Cuttsy + Cuttsy

    If a patient was given their results directly, how could we make it into something they could understand and, most importantly, act on?